Data protection Impressum

Digital Health

The CHUV in Lausanne has inaugurated the state-of-the-art Swiss BioMotion Lab, which offers innovative solutions for the study and treatment of osteoarthritis through cutting-edge motion analysis.

CHUV inaugurates Swiss BioMotion Lab for advanced osteoarthritis research and treatment

23 September 2024

The Swiss Center for Electronics and Microtechnology (CSEM) marks its 40th anniversary in 2024, celebrating four decades of pioneering technology development and industry partnerships that have shaped the future of microtechnology, digitalization, and sustainability.

CSEM celebrates 40 years of innovation and industry collaboration in Neuchâtel

18 September 2024

NOA by biped marks successful market entry in Europe and the US

6 August 2024

Geneva-based Agora Care has closed a financing round of CHF 2.2 million to support its expansion into the US market and increase patient enrollment in Switzerland and Europe.

Medical imaging specialist Agora Care secures CHF 2.2 million for US market expansion

5 August 2024

Biopôle is joining forces with Swiss Healthcare Startups to extend the Vanguard accelerator to digital health start-ups in German-speaking Switzerland, while also welcoming Hôpital de La Tour to its Corporate Partnership Programme.

Biopôle expands its accelerator program and welcomes new corporate partner

5 August 2024

Revinax, founded in 2015 by neurosurgeon Maxime Ros in Montpellier, has decided to expand its activities by setting up at the Biopôle in Lausanne.

French company Revinax establishes operations at the Biopôle in Lausanne

3 July 2024

BioAlps, the life sciences cluster of Western Switzerland, offers a dynamic network, an innovative and supportive environment and direct access to the region's vibrant life sciences ecosystem.

BioAlps, Western Switzerland’s life sciences cluster

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2024)

26 June 2024

Doctolib, a leading European healthtech company based in Berlin, has announced the acquisition of Typeless, an EPFL spin-off specializing in AI speech recognition technology.

Doctolib acquires Typeless to enhance AI capabilities in healthcare

24 June 2024

Aktiia has received CE mark approval for its non-cuff optical technology, enabling the start-up to access markets in over 40 countries.

Aktiia’s CE Mark approval opens doors to international expansion

17 June 2024

1 … 4 5 6 7 8 9 10 11 12 … 15